NHS Pharmacy Flu Service


Guidance on Flu Vaccination Advanced Service 20/21

Following the publication of the service specification for the 2020/21 Community Pharmacy Seasonal Influenza Vaccination Advanced Service and the associated national Patient Group Direction (PGD) on Friday 28th August, the PSNC Services Team has been busy updating their guidance and resources on the service. Contractors may wish to view the following:

  • PSNC Briefing 026/20: Guidance on the 2020/21 Seasonal Influenza Vaccination Advanced Service: This briefing replaces PSNC’s earlier guidance, with full information on the service requirements, new flexibilities and the practical issues that contractors need to consider before using them.
  • Record keeping and data requirements: From September 2020, the requirement for a patient to sign a consent form has been removed from the service requirements. This page describes what records are required.
  • Vaccinating outside the consultation room & off-site: This page describes the flexibilities and approaches for the 2020/21 Seasonal Influenza Vaccination Advanced Service.
  • Frequently Asked Questions (FAQs): This page contains the answers to Frequently Asked Questions (FAQs) on the Flu Vaccination Service. It will be updated as we receive and address more queries.

Links to further information and resources can be found on the PSNC website: psnc.org.uk/flu


Accessing Additional Stock

Guidance has now been published on how community pharmacies will be able to access supplies of flu vaccines procured centrally by the Government.

As previously communicated, the stock procured by DHSC will start to be delivered in November and supplies will also be received in December.

The DHSC has worked with PSNC to develop a process for accessing the stock, giving consideration to the supply route via which pharmacies normally receive their flu vaccines and seeking to limit the impact on the business as usual supply chains. In developing the process, DHSC has also needed to protect and mitigate the risks of unintended use, as the stock procurement is a taxpayer funded programme.

Full details on the use and ordering of this stock